The alloimmune response to the human platelet antigen-1a is not related to maternal-fetal killer immunoglobulinlike receptor/HLA-Cw combinations

Transfusion

Volumn 47, Issue 12, 2007, Pages 2322-2329

  Valentin, Nathalie ^a   Gagne, Katia ^b   Kerdudou, Nolwenn ^b   Hallé, Liliane ^b   Kaplan, Cécile ^b   Killie, Mette Kjaer ^b   Skogen, Bjorn ^b   Muller, Jean Yves ^b   Bignon, Jean Denis ^b  

^a INSTITUT DE BIOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; KILLER IMMUNOGLOBULINLIKE RECEPTOR; PLATELET ANTIGEN 1A; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HLA SYSTEM; HUMAN; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MOTHER FETUS RELATIONSHIP; SIBLING; THROMBOCYTOPENIA;

ANTIGENS, HUMAN PLATELET; FEMALE; GENOTYPE; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MATERNAL-FETAL EXCHANGE; PREGNANCY; RECEPTORS, KIR;

EID: 36348950195     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01450.x     Document Type: Article

References (30)

1. Murphy MF, Williamson LM, Urbaniak SJ. Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sang 2002 83 (Suppl 1 409 16.
2. Spencer JA, Burrows RF. Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001 41 : 45 55.
3. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998 92 : 2280 7.
4. Jaegtvik S, Husebekk A, Aune B, Oian P, Dahl LB, Skogen B. Neonatal alloimmune thrombocytopenia due to anti-HPA 1a antibodies; the level of maternal antibodies predicts the severity of thrombocytopenia in the newborn. BJOG 2000 107 : 691 4.
5. Valentin N, Vergracht A, Bignon JD, Cheneau ML, Blanchard D, Kaplan C, Reznikoff-Etievant MF, Muller JY. HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Hum Immunol 1990 27 : 73 9.
6. L'Abbe D, Tremblay L, Filion M, Busque L, Goldman M, Décary F, Chartrand P. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 1992 34 : 107 14.
7. Sukati H, Bessos H, Barker RN, Urbaniak SJ. Characterization of the alloreactive helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1a alloimmunized human platelet antigen-1b1b women. Transfusion 2005 45 : 1165 77.
8. Wu S, Maslanka K, Gorski J. An integrin polymorphism that defines reactivity with alloantibodies generates an anchor for MHC class II peptide binding: a model for unidirectional alloimmune responses. J Immunol 1997 158 : 3221 6.
9. Maslanka K, Yassai M, Gorski J. Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. J Clin Invest 1996 98 : 1802 8.
10. Jackson DJ, Murphy MF, Soothill PW, Lucas GF, Elson CJ, Kumpel BM. Reactivity of T cells from women with antibodies to the human platelet antigen (HPA)-1a to peptides encompassing the HPA-1 polymorphism. Clin Exp Immunol 2005 142 : 92 102.
11. Bertrand G, Martageix C, Jallu V, Vitry F, Kaplan C. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006 4 : 628 37.
12. Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion 2007 47 : 55 8.
13. Trowsdale J, Betz AG. Mother's little helpers: mechanisms of maternal-fetal tolerance. Nat Immunol 2006 7 : 241 6.
14. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006 7 : 277 300.
15. Carrington M, Martin MP. The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol 2006 298 : 225 57.
16. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003 198 : 1201 12.
17. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, Prus D, Cohen-Daniel L, Arnon TI, Manaster I, Gazit R, Yutkin V, Benharroch D, Porgador A, Keshet E, Yagel S, Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 2006 12 : 1065 74.
18. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004 200 : 957 65.
19. Ruggeri L, Aversa F, Martelli MF, Velardi A. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol Rev 2006 214 : 202 18.
20. Bignon JD, Gagne K. KIR matching in hematopoietic stem cell transplantation. Curr Opin Immunol 2005 17 : 553 9.
21. Denis L, Sivula J, Gourraud PA, et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005 66 : 267 76.
22. Gebuhrer L, Betuel H. Caucasian French normals. In : Terasaki PI, Gjertson DW, editors. HLA 1998. Mt Laurel (NJ) : American Society for Histocompatibility & Immunogenetics 1998. p. 142.
23. Meyer D, Single RM, Mack SJ, et al. Single locus polymorphism of classical HLA genes. In : Hansen J, editor. Immunobiology of the human MHC. Proceedings of the 13th International Histocompatibility Workshop and Congress 2002. Seattle : International Histocompatibility Working Group Press 2006.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 16 : 1215.
25. Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 2003 64 : 648 54.
26. Witt CS, Christiansen FT. The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation. Vox Sang 2006 90 : 10 20.
27. Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E International Histocompatibility Working Group. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant 2006 12 : 828 36.
28. O'Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 2007 178 : 235 41.
29. Parham P. Immunology. NK cells lose their inhibition. Science 2004 305 : 786 7.
30. Sayeh E, Aslam R, Speck ER, Le-Tien H, Lazarus AH, Freedman J, Semple JW. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype. Transfusion 2004 44 : 1572 8.